Ahead of his Ophthalmologica Lecture at the Euretina Congress in Vienna, Dr. Elon van Dijk joins Ophthalmologica Editor-in-Chief Prof. Martin Zinkernagel to explain why central serous chorioretinopathy remains so hard to pin down — and what multimodal imaging can tell us about which eyes will resolve on their own. They discuss the evidence behind half-dose PDT, the trials that got us there, and the career choices behind the lecture
Podden och tillhörande omslagsbild på den här sidan tillhör
Whipsmart Media. Innehållet i podden är skapat av Whipsmart Media och inte av,
eller tillsammans med, Poddtoppen.
